408 filings
Page 4 of 21
8-K
9rxsnbhj 3yo7fsmc0
1 May 19
Innoviva Reports First Quarter 2019 Financial Results
4:25pm
8-K
2fkwr
25 Apr 19
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
zlzjovw2if gw8h
28 Feb 19
Changes in Registrant's Certifying Accountant
4:36pm
8-K
wu0bld1x
6 Feb 19
Innoviva Reports Fourth Quarter 2018 Financial Results
4:28pm
8-K
s3nli0dquw h1
31 Oct 18
Innoviva Reports Third Quarter 2018 Financial Results
4:18pm
8-K
dm6g xpvu8uuj05
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
l8fac3w5hu o14ab5
1 Oct 18
Departure of Directors or Certain Officers
12:00am
8-K
rqxic1m2rc1fmu8n
11 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
ox4uhzkkh66 yc670hgq
8 Aug 18
Departure of Directors or Certain Officers
4:44pm
8-K
1bscc26607 w3jy
2 Aug 18
Other Events
4:31pm
8-K
g7ab4k ft81h
26 Jul 18
Innoviva Reports Second Quarter 2018 Financial Results
4:10pm
8-K
x46p rzvbgzxf5kc
23 May 18
Departure of Directors or Certain Officers
12:00am
8-K
0i2tyo xgd5z37n8ht2r
26 Apr 18
Innoviva Reports First Quarter 2018 Financial Results
12:00am
8-K
kn1phhdp8 rgxs5fm77u
24 Apr 18
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD
12:00am
8-K
dkbharey ol
28 Feb 18
Other Events
12:00am
8-K
x31xj0y687la195
13 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
zp04cbh2 t6va5
8 Feb 18
Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
0kqppkwq2ar
7 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
stjxbqipe8sy5
26 Jan 18
GSK announces CHMP positive opinion for labelling update to Relvar Ellipta in patients with asthma
12:00am
8-K
p9uxkg
10 Jan 18
Amendments to Articles of Incorporation or Bylaws
12:00am